Novel Mutations in the CPT1A Gene Identified in the Patient Presenting Jaundice as the First Manifestation of Carnitine Palmitoyltransferase 1A Deficiency

Jong-Sub CHOI; Hyeoh-Won YOO; Kyung-Jae LEE; Jung-Min KO; Jin-Soo MOON; Jae-Sung KO.
Pediatric Gastroenterology, Hepatology & Nutrition ; : 76-81, 2016.
Artículo en Inglés | WPRIM | ID: wpr-158488

Documentos relacionados

  1. [Analysis of a child with carnitine palmitoyl transferase 1A deficiency due to variant of CPT1A gene].
  2. Cardiolipin Stabilizes and Increases Catalytic Efficiency of Carnitine Palmitoyltransferase II and Its Variants S113L, P50H, and Y479F.
  3. Malonyl-CoA Accumulation as a Compensatory Cytoprotective Mechanism in Cardiac Cells in Response to 7-Ketocholesterol-Induced Growth Retardation.
  4. [Clinical features and genetic variants of a case with carnitine palmitoyltransferase 1A deficiency].
  5. Experience with carnitine palmitoyltransferase II deficiency: diagnostic challenges in the myopathic form.
  6. Case Study of an Elderly Patient With New Onset Weakness.
  7. CPT1A-mediated fatty acid oxidation confers cancer cell resistance to immune-mediated cytolytic killing.
  8. Clinical characteristics and genetic analysis of six children with carnitine palmitoyltransferase 2 deficiency.
  9. Carnitine palmitoyl transferase I: Conformational changes induced by long-chain fatty acyl CoA ligands.
  10. Unique Behavior of Bacterially Expressed Rat Carnitine Palmitoyltransferase 2 and Its Catalytic Activity.